CLINICAL TRIALS PROFILE FOR ISUPREL
✉ Email this page to a colleague
All Clinical Trials for ISUPREL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02615119 ↗ | Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa | Recruiting | National Institute of Mental Health (NIMH) | N/A | 2015-10-01 | This study aims to identify the brain regions responsible for encoding cardiorespiratory 'interoceptive' sensations and determine whether they are dysfunctional in individuals affected by eating disorders, anxiety, depression, or brain injury. By evaluating the same interoceptive sensations across different human illnesses, the investigators hope to provide convergent evidence resulting in identification of core underlying neural processes, and to discern relative contributions in each condition. |
NCT02615119 ↗ | Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa | Recruiting | Laureate Institute for Brain Research, Inc. | N/A | 2015-10-01 | This study aims to identify the brain regions responsible for encoding cardiorespiratory 'interoceptive' sensations and determine whether they are dysfunctional in individuals affected by eating disorders, anxiety, depression, or brain injury. By evaluating the same interoceptive sensations across different human illnesses, the investigators hope to provide convergent evidence resulting in identification of core underlying neural processes, and to discern relative contributions in each condition. |
NCT02673996 ↗ | POTS Adrenergic Ab (CIHR Aims #1&2) | Recruiting | University of Calgary | 2016-01-01 | Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS. | |
NCT02725060 ↗ | Autoimmune Basis for Postural Tachycardia Syndrome | Enrolling by invitation | University of Oklahoma | N/A | 2016-02-01 | The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time. |
NCT02725060 ↗ | Autoimmune Basis for Postural Tachycardia Syndrome | Enrolling by invitation | Vanderbilt University | N/A | 2016-02-01 | The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time. |
NCT02725060 ↗ | Autoimmune Basis for Postural Tachycardia Syndrome | Enrolling by invitation | Vanderbilt University Medical Center | N/A | 2016-02-01 | The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time. |
NCT03019081 ↗ | Augmented Interoceptive Exposure Training in Anorexia Nervosa | Active, not recruiting | Brain & Behavior Research Foundation | N/A | 2017-01-01 | The researchers propose to utilize a pharmacological approach involving infusions of the sympathomimetic agent isoproterenol to repeatedly trigger cardiorespiratory sensations and anxiety during meal anticipation, to facilitate the development of tolerance or a reduction of the anxiety/fear response in individuals with anorexia nervosa. The investigators aim to conduct a proof of principle study to assess for evidence of initial efficacy of this new treatment approach. As a comparator condition, the researchers propose using repeated administration of saline infusions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ISUPREL
Condition Name
Clinical Trial Locations for ISUPREL
Trials by Country
Clinical Trial Progress for ISUPREL
Clinical Trial Phase
Clinical Trial Sponsors for ISUPREL
Sponsor Name